New phthalazine-derived compound as a sos1 inhibitor and use thereof.
CL202600868A1Pending Publication Date: 2026-07-17HANMI PHARM CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202600868
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-06-28
- Filing Date
- 2026-03-24
- Publication Date
- 2026-07-17
Abstract
Novel phthalazine-derived compounds are described as an inhibitor of SOS1 and their use, and more particularly novel phthalazine-derived compounds with SOS1 binding inhibition activity to RAS and / or RAC1 family proteins, their pharmaceutically acceptable derivatives, or a pharmaceutical composition containing such compound.
Need to check novelty before this filing date? Find Prior Art